Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats

European Journal of Immunology

Volumn 34, Issue 12, 2004, Pages 3508-3515

  Palaniyandi, Suresh S ^a   Watanabe, Kenichi ^a   Ma, Meilei ^a   Tachikawa, Hitoshi ^b   Kodama, Makoto ^b   Aizawa, Yoshifusa ^b  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Gene therapy and mast cells; Interleukin 10

Indexed keywords

CARDIAC MYOSIN; CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; HISTAMINE; INTERLEUKIN 10; PLASMID VECTOR; TOLONIUM CHLORIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DENSITY; CELL GROWTH; CONTROLLED STUDY; DEGRANULATION; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROPORATION; FIBROSIS; GENE TRANSFER; HEART FUNCTION; HEART PROTECTION; HEART VENTRICLE; HEART WEIGHT; HEMODYNAMICS; IMMUNIZATION; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; MAST CELL; MICROSCOPY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STAINING; TIBIALIS ANTERIOR MUSCLE; TISSUE SECTION;

ANIMALS; ELECTROPORATION; GENE THERAPY; HISTAMINE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; MAST CELLS; MICE; MYOCARDITIS; MYOCARDIUM; RATS; STEM CELL FACTOR;

EID: 10944253672     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425147     Document Type: Article

References (48)

1. Kodama, M., Matsumoto, Y., Fujiwara, M., Masani, F., Izumi, T. and Shibata, A., A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 1990. 57: 250-262.
2. Kodama, M., Matsumoto, Y., Fujiwara, M., Zhang, S., Hanawa, H., Itoh, E., Tsuda, T., Izumi, T. and Shibata, A., Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ. Res. 1991. 69: 1042-1050.
3. Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M. J., Schofield, B. H., Hill, S. L. and Rose, N. R., Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 2001. 159: 193-203.
4. Kodama, M., Okura, Y., Aizawa, Y. and Izumi, T., Animal models of autoimmune myocarditis. In Cooper, L. T., Jr. (Ed.) Myocarditis: from bench to bedside. Humana Press, New Jersey 2003, pp 197-214.
5. Neu, N., Ploier, B. and Ofner, C., Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J. Immunol. 1990. 145: 4094-4100.
6. Smith, S. C. and Allen, P. M., Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991. 147: 2141-2147.
7. Penninger, J. M., Neu, N., Timms, E., Wallace, V. A., Koh, D. R., Kishihara, K., Pummerer, C. and Mark, T. W., The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules. J. Exp. Med. 1993. 178: 1837-1842.
8. Kodama, M., Matsumoto, Y. and Fujiwara, M., In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 1992. 85: 1918-1926.
9. Hanawa, H., Kodama, M., Inomata, T., Izumi, T., Shibata, A., Tuchida, M., Matsumoto, Y. and Abo, T., Anti-αβ T cell receptor antibody prevents the progression of experimental autoimmune myocarditis. Clin. Exp. Immunol. 1994. 96: 470-475.
10. Pummerer, C., Berger, P., Fruhwirth, M., Ofner, C. and Neu, N., Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab. Invest. 1991. 65: 538-547.
11. Bingham, C. O., 3rd and Austen, K., Mast cell responses in the development of asthma. J. Allergy Clin. Immunol. 2000. 105: S527-S534.
12. Huang, C., Friend, D. S., Qiu, W. T., Wong, G. W., Morales, G., Hunt, J. and Stevens, R. L., Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 1998. 160: 1910-1919.
13. Esposito, I., Friess, H., Kappeler, A., Shrikhande, S., Kleeff, J., Ramesh, H., Zimmermann, A. and Buchler, M. W., Mast cell distribution and activation in chronic pancreatitis. Hum. Pathol. 2001. 32: 1174-1183.
14. Panizo, A., Mindan, F. J., Galindo, M. F., Cenarruzabeitia, E., Hernandez, M. and Diez, J., Are mast cells involved in hypertensive heart disease? J. Hypertens. 1995. 13: 1201-1208.
15. Jolly, S. R., Abrams, G. D., Romson, J. L., Bailie, M. B. and Lucchesi, B. R., Effects of lodoxamide on ischemic reperfused myocardium. J. Cardiovasc. Pharmacol. 1982. 4: 441-448.
16. Patella, V., Marino, I., Arbustini, E., Lamparter-Schummert, B., Verga, L., Adt, M. and Marone, G., Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998. 97: 971-978.
17. Zweifel, M., Hirisiger, H., Matozan, K., Welle, M., Schaffner, T. and Mohacsi, P., Mast cells in ongoing acute rejection: increase in number and expression of a different phenotype in rat heart transplants. Transplantation 2002. 73: 1707-1716.
18. Fernex, M., The mast cell system: its relationship to atherosclerosis, fibrosis and eosinophils. Williams and Wilkins, Baltimore 1968
19. Li, C. Y. and Baek, J. Y., Mastocytosis and fibrosis: role of cytokines . Int. Arch. Allergy Immunol. 2002. 127: 123-126.
20. Pappas, P. J., You, R., Rameshwar, P., Gorti, R., DeFouw, D. O., Phillips, C. K., Padberg, F. T., Jr., Silva, M. B., Jr., Simonian, G. T., Hobson, R. W., 2nd and Duran, W. N., Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta 1 gene expression and protein production. J. Vasc. Surg. 1999. 30: 1129-1145.
21. Wang, M., Wang, T. and Liu, L., The role of mast cells in myocardial fibrosis in SHRsp. Zhonghua Bing Li Xue Za Zhi 1998. 27: 182-184.
22. Paolocci, N., Sironi, M., Bettini, M., Bartoli, G., Michalak, S., Bandi, C., Magni, F. and Bruschi, F., Immunopathological mechanisms underlying the time-course of Trichinella spiralis cardiomyopathy in rats. Virchows Arch. 1998. 432: 261-266.
23. Valent, P., Schernthaner, G. H., Sperr, W. R., Fritsch, G., Agis, H., Willheim, M., Buhring, H. J., Orfao, A. and Escribano, L., Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol. Rev. 2001. 179: 74-81.
24. Royer, B., Varadaradjalou, S., Saas, P., Gabiot, A. C., Kantelip, B., Feger, F., Guillosson, J. J., Kantelip, J. P. and Arock, M., Autocrine regulation of cord-derived human mast cell activation by IL-10. J. Allergy Clin. Immunol. 2001. 108: 80-86.
25. Okura, Y., Yamamoto, T., Goto, S., Inomata, T., Hirono, S., Hanawa, H., Feng, L., Wilson, C. B., Kihara I., Izumi T. et al., Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Mol. Cell. Cardiol. 1997. 29: 491-502.
26. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1995. 16: 34-38.
27. Fiorentino, D. F., Bond, M. W., Mosmann, T. R. and Ward, P. A., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 2081-2095.
28. Aihara, H. and Miyazaki, J., Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 1998. 16: 867-870.
29. Maruyama, H., Sugawa, M., Moriguchi, Y., Imazeki, I., Ishikawa, Y., Ataka, K., Hasegawa, S. Ito, Y., Higuchi, N., Kazama, J. J. et al., Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Hum. Gene Ther 2000. 11: 429-437.
30. Nakano, A., Matsumori, A., Kawamoto, S., Tahara, H., Yamato, E., Sasayama, S. and Miyazaki, J. I., Cytokine gene therapy for myocarditis by in vivo electroporation. Hum. Gene Ther. 2001. 12: 1289-1297.
31. Kalsner, S. and Richards, R., Coronary arteries of cardiac patients are hyper-reactive and contain stores of amines: a mechanism for coronary spasm. Science 1984. 223: 1435-1437.
32. Forman, M. B., Oates, J. A., Robertson, D., Robertson, R. M., Roberts, L. J. and Viramani, R., Increased adventitial mast cells in a patient with coronary spasm. N. Engl. J. Med. 1985. 313: 1138-1141.
33. Kaartinen, M., Penttila, A. and Kovanen, P. T., Mast cells of two types differing in neutral protease composition in the human aortic intima: demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and in shoulder region of atheromas. Arterioscler Thromb. 1994. 14: 966-972.
34. Lichtbroun, A. S., Sandhus, L. M., Giorno, R. C., Kim, H. and Seibold, J. R., Myocardial mast cells in systemic sclerosis: a report of three fatal cases. Am. J. Med. 1990. 89: 372-376.
35. Shelburne, C. P. and Ryan, J. J., The role of Th2 cytokines in mast cell homeostasis. Immunol. Rev. 2001. 179: 82-93.
36. Watanabe, K., Nakazawa, M., Fuse, K., Hanawa, H., Kodama, M., Aizawa, Y., Ohnuki, T., Gejyo, F., Maruyama, H. and Miyazaki, J., Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001. 104: 1098-1100.
37. Tsai, M., Takeishi, T., Thompson, H., Langely, K. E., Zsebo, K. M., Metcalfe, D. D., Geissler, E. N. and Galli, S. J., Induction of mast cell proliferation, maturation and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 1991. 88: 6382-6386.
38. Columbo, M., Horowitz, E. M., Botana, L. M., MacGlashan, D. W., Jr., Bochner, B. S., Gillis, S., Zsebo, K. M., Galli, S. and Lichtenstein, L. M., The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 1992. 149: 599-608.
39. Nilsson, G., Miettinen, U., Ishizaka, T., Ashman, L. K., Irani, A. M. and Schwartz, L. B., Interleukin-4 inhibits the expression of kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 1994. 84: 1519-1527.
40. Costa, J. J., Demetri, G. D., Harrist, T. J., Dvorak, A. M., Hayes, D. F., Merica, E. A., Menchaca, D. M., Gringeri, A. J., Schwartz L. B. and Galli, S. J., Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J. Exp. Med. 1996. 183: 2681-2686.
41. Valent, P., Spanblochl, E., Sperr, W. R., Sillaber, C., Zsebo, K. M., Agis, H., Strobl, H., Geissler, K., Bettelheim, P. and Lechner, K., Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992. 9: 2237-2245.
42. Walsh, L. J., Trinchieri, G., Waldorf, H. A., Whitaker, D. and Murphy, G. F., Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 1991. 88: 4220-4224.
43. Galli, S. J., New concepts about the mast cell. N. Engl. J. Med. 1993. 328: 257-265.
44. Levi-Schaffer, F. and Rubinchik, E., Activated mast cells are fibrogenic for 3T3 fibroblasts. J. Invest. Dermatol. 1995. 104: 999-1003.
45. Pennington, D. W., Ruoss, S. J. and Gold, W. M., Dog mastocytoma cells secrete a growth factor for fibroblasts. Am. J. Respir. Cell. Mol. Biol. 1992. 6: 625-632.
46. Kodama, M., Hanawa, H., Saeki, M., Hosono, H., Inomata, T., Suzuki, K. and Shibata, A., Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ. Res. 1994. 75: 278-284.
47. Watanabe, K., Ohta, Y., Nakazawa, M., Higuchi, H., Hasegawa, G., Naito, M., Fuse, K., Ito, M., Hirono, S., Tanabe, N. et al., Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br. J. Pharmacol. 2000. 130: 1489-1495.
48. Anton, A. H. and Sayre, D. F., A modified fluorometric procedure for tissue histamine and its distribution in various animals. J. Pharmacol. Exp. Ther. 1969. 166: 285-292.